Collaboration agreement within IUI, Intra-Uterine Insemination

Vitrolife is entering into a collaboration agreement with ParentPlus LLC, with the aim of developing new products for IUI (Intra-Uterine Insemination, artificial insemination).In many countries IUI treatment is a requirement before IVF (In Vitro Fertilization) treatment can begin. It is estimated that there is a market for between 4-6 million treatments a year, with a market value of SEK 1-2 billion. IUI, “artificial insemination”, is a process where the sperm are prepared by separating them from the seminal fluid and then injecting them so that a high concentration of active and mobile